Dr. Alok Kanojia (Dr. K)

speaker

1,658 appearances 5 recordings 3 series first heard Sep 2025 last heard 27 May

Dr. Alok Kanojia (Dr. K)’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 4 in all, peaking in Oct 2025 with 2.

Appearances

newest first · ▶ plays the moment

HealthyGamerGG · How Psychedelics Unlock Your Brain’s “Edit Mode” · 13 Oct 2025 podcast

So they'll trip so hard that it'll basically be like a PTSD inducing experience.

Their physiological wiring changes to where they're constantly anxious, their adrenaline is pumping, their cortisol levels are high.

And remember, we're putting the brain and body, the physiology, into an edit mode.

So when the psychedelic trip ends, they're control-S-ing, and they're basically locking their nervous system into a highly stressful state.

I've seen the development of PTSD.

I've seen the development of things like panic disorder, which are also like the reason that you develop a panic disorder is because your physiology has been locked into a highly anxious state.

And so if psychedelics can be incredibly damaging.

and they can be incredibly healing, how does that work?

And if we understand that what they basically do is allow us to edit our brain, this starts to make sense, right?

Because if I'm editing my brain, but the experience that I'm having is incredibly negative and traumatic, then I will sort of wire my brain in a traumatized way, wire my physiology in a traumatized way.

But if I have a positive experience with psychedelics,

then I will have a sort of positive, you know, wiring, if that kind of makes sense.

So what psychedelics basically do is turn our brain into edit mode where we can start editing the source code.

So what that means is that the kind of edits that we make are ultimately what makes psychedelics potentially therapeutic or potentially harmful, right?

So really all they do is allow us to edit.

Then the code that we put in is ultimately what's important.

And this is what the studies show.

So just to give you all an example of like, you know, what studies on psychedelics actually look like, what we'll do is we'll take like a patient or a set of patients.

And for 12 to 14 weeks, we'll have like a 14 week study on psychedelics.

What these people will do is they will go to a medical clinic where they will work with a therapist for the period of 14 weeks.

Showing 321–340 of 1,658 · page 17 of 83